Title : Role of cancer immunology in chronic myelogenous leukemia.

Pub. Date : 2020 Jan

PMID : 31765938






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Chronic myelogenous leukemia (CML) is caused by the BCR-ABL chimeric tyrosine kinase, which is derived from the reciprocal translocation, t(9;22)(q34;q11). Tyrosine ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 BCR-ABL tyrosine kinase inhibitors (TKIs) can provide prolonged overall survival in CML patients, resulting in life expectancy nearly to general population, and now approximately half of patients who achieved deep molecular response (DMR) can sustain durable molecular remission after discontinuation TKIs. Tyrosine ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens